Fas-associated factor 1 mediates NADPH oxidase-induced reactive oxygen species production and proinflammatory

Tae-Hwan Kim1, Hyun-Cheol Lee1, Jae-Hoon Kim1,2

  • 1College of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea.

Plos Pathogens
|August 15, 2019
PubMed

Insights

Fas-associated factor 1 (FAF1) activates NADPH oxidase in macrophages, enhancing bacterial defenses against Listeria monocytogenes. This protein is crucial for producing reactive oxygen species and mounting an effective immune response.

Area of Science:

  • Immunology
  • Cell Biology
  • Microbiology

Background:

  • Fas-associated factor 1 (FAF1) is known to regulate apoptosis and interact with various proteins.
  • The specific role of FAF1 in bacterial infection defense was previously undefined.

Purpose of the Study:

  • To investigate the function of FAF1 in macrophage response to Listeria monocytogenes infection.
  • To elucidate the mechanism by which FAF1 influences antibacterial activity.

Main Methods:

  • Investigated FAF1 interaction with p67phox in macrophages during L. monocytogenes infection.
  • Assessed the impact of FAF1 knockdown and overexpression on reactive oxygen species (ROS) and cytokine production.
  • Utilized FAF1gt/gt mice to evaluate in vivo inflammatory responses and bacterial load.

Main Results:

  • FAF1 directly interacts with p67phox, stabilizing it and enhancing NADPH oxidase activity.
  • FAF1 modulation significantly affects ROS production, pro-inflammatory cytokine release, and antibacterial activity in macrophages.
  • FAF1gt/gt mice exhibit diminished inflammatory responses and increased L. monocytogenes replication.

Conclusions:

  • FAF1 plays a critical role in activating NADPH oxidase-dependent ROS production during bacterial infection.
  • FAF1 enhances macrophage antibacterial defenses against Listeria monocytogenes.
  • FAF1 is a key positive regulator of innate immunity against bacterial pathogens.

Related Concept Videos

Murine Nasal Lavage Fluid Collection without Blood Contamination05:12

Murine Nasal Lavage Fluid Collection without Blood Contamination

The present protocol describes a novel method for avoiding blood contamination in murine nasal lavage fluid (NLF). Since this method ensures the NLF collection without blood contamination, it allows for more accurate detections of immunological components and various respiratory...
1.7K
Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

OSTSS leads to pooled inflammatory mediators in the tear film, causing symptoms like epiphora and discomfort. Here, we present a case where therapeutic nasolacrimal lavage every 2 months resolved epiphora and itchiness, suggesting its efficacy as a therapeutic intervention for OSTSS. Additionally, we report subjective improvements in symptoms in 3 additional...
1.1K
Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment04:35

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

Saline nasal lavage can be used to sample the canine nasal immune microenvironment. Because the approach is relatively non-invasive and does not disrupt the nasal tissues, it can be performed serially. Cells and proteins collected from the nasal lavage technique can be processed for various laboratory analyses.
880
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

A protocol for conducting a challenge in an allergen exposure chamber (AEC) facility is presented. AECs have proven to be safe and effective tools for the induction of allergic symptoms or as an endpoint in the efficacy testing of allergen immunotherapy due to their ability to maintain stable particle concentrations and environmental...
2.9K
Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Batrachochytrium dendrobatidis infection in amphibians can be eliminated using a reduced concentration (0.0025%) and shorter duration (five minute baths for six days) of itraconazole than is generally used. Less mortality and fewer negative side effects were observed using this modified treatment...
12.0K
Intranasal Administration of CNS Therapeutics to Awake Mice07:15

Intranasal Administration of CNS Therapeutics to Awake Mice

A method to intranasally administer drugs to awake mice for the purpose of targeting the brain is described. This method allows for repeat dosing over long periods using intranasal administration of drug without anesthesia, and nose-to-brain delivery with minimal systemic...
61.4K